Access cutting-edge irritable bowel syndrome treatment through this clinical trial at a research site in Hot Springs. Study-provided care at no cost to qualified participants.
Access irritable bowel syndrome specialists in Hot Springs at no cost
This study follows strict safety protocols and ethical guidelines
All study-related irritable bowel syndrome treatment provided free
The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating irritable bowel syndrome with diarrhea (IBS-D) in pediatric participants 6-17 years of age, to evaluate the pharmacokinetics of eluxadoline in pediatric participants with IBS-D, and to evaluate the safety and tolerability of eluxadoline in pediatric participants with IBS-D. Enrollment of 12-17 years old age group is closed, enrollment of the 6-11 years old age group will continue.
Sponsor: AbbVie
Check if you qualify for this irritable bowel syndrome clinical trial in Hot Springs, AR
If you're searching for irritable bowel syndrome treatment options in Hot Springs, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hot Springs research site is actively enrolling participants for this clinical trial. You'll receive care from experienced irritable bowel syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.